I+D

I+D

I+D (2)

I+D (2)

I+D (3)

I+D (3)

I+D (4)

I+D (4)

INNOCHAG

One of the strategic lines of Praxis Group is focused in solutions to fight the health problems caused by poverty related diseases. Classified as neglected disease by the WHO, Chagas is caused by the parasite Trypanosoma cruzi. Is a serious health problem in Latin America and is an emerging disease in non-endemic areas such as several countries in Europe, USA, Canada and western pacific. In recent decades, the epidemiological profile of the disease has changed due to new patterns of immigration, leading to the urbanization and globalization of the disease and coming up to an estimation of 12 million people infected.

The INNOCHAG Project aims to develop new diagnostic tools and therapies to combat Chagas by creating new products that help to dismiss the high impact of this social and economic concern. More specifically, the INNOCHAG project has developed a set of immunological biomarkers against which the reactivity of sera from Chagas disease patients could be modified by anti-chagasic treatment, thus providing potential predictive diagnostic value.

These solutions in diagnosis are based on three fundamental pillars related to the peculiarity of this disease:

Improvement in therapeutic efficacy and monitoring of the patients, easy implementation and low cost solutions.


figura inncochag

 

The INNOCHAG Project: "INNOVATION AND ADVANCED DEVELOPMENT OF BIOTECHNOLOGIES FOR DIAGNOSIS AND TREATMENT OF CHAGAS DISEASE”, RTC-2014-2130-1 Is being  developed by the INSTITUTO LOPEZ NEYRA from The Spanish National Research Council (CSIC) and the companies BIOKILAB and PRAXIS BIOPHARMA and has been granted by  the National Programme for Research - Challenges of Society in the frame of the Scientific and Technical Investigation and Innovation National Plan 2013-2016.


Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración, en nuestro enlace Políticas de Seguridad. We use our own cookies and third-party cookies to improve our services and show related advertising to your preferences by analyzing their browsing habits. If you continue to browse, consider accepting its use. You can get more information, or how to change the settings in our Política de privacidad.